Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Jan;16(1):91-97.
doi: 10.1016/j.jcf.2016.07.011. Epub 2016 Aug 15.

Cancer risk among lung transplant recipients with cystic fibrosis

Affiliations

Cancer risk among lung transplant recipients with cystic fibrosis

Aliza K Fink et al. J Cyst Fibros. 2017 Jan.

Abstract

Background: Previous studies demonstrated increased digestive tract cancers among individuals with cystic fibrosis (CF), particularly among lung transplant recipients. We describe cancer incidence among CF and non-CF lung recipients.

Methods: We used data from the US transplant registry and 16 cancer registries. Standardized incidence ratios (SIRs) compared cancer incidence to the general population, and competing risk methods were used for the cumulative incidence of colorectal cancer.

Results: We evaluated 10,179 lung recipients (1681 with CF). Risk was more strongly increased in CF recipients than non-CF recipients for overall cancer (SIR 9.9 vs. 2.7) and multiple cancers including colorectal cancer (24.2 vs. 1.7), esophageal cancer (56.3 vs. 1.3), and non-Hodgkin lymphoma (61.8 vs. 9.4). At five years post-transplant, colorectal cancer was diagnosed in 0.3% of CF recipients aged <50 at transplant and 6.4% aged ≥50.

Conclusions: CF recipients have increased risk for colorectal cancer, suggesting a need for enhanced screening.

Keywords: Cancer; Transplant.

PubMed Disclaimer

Figures

Figure 1:
Figure 1:. Standardized Incidence Ratios for Selected Cancers among CF and Non-CF Lung Recipients
The figure shows standardized incidence ratios (circles) and 95% confidence intervals (vertical lines) among lung recipients with and without cystic fibrosis (CF). Results are shown for cancer for which there was at least 1 observed case among recipients with CF. Cancers for which the SIR for CF recipients is statistically significantly different from the SIR for non-CF recipients are marked by a ★
Figure 2:
Figure 2:. Standardized Incidence Ratios of Colorectal Cancer for CF and Non-CF Lung Recipients, by Colorectal Subsite
The figure shows standardized incidence ratios (circles) and 95% confidence intervals (vertical lines) among lung recipients with and without cystic fibrosis (CF). Results are shown for colorectal cancer overall and for cancers arising in colorectal subsites
Figure 3:
Figure 3:. Cumulative Incidence of Colorectal Cancer in Lung Recipients, by CF Status and Age at Transplant
The figure shows the cumulative incidence of colorectal cancer among lung recipients according to reason for transplant and age at transplant. Black lines correspond to estimates for recipients with cystic fibrosis (CF) and gray lines correspond to estimates for recipients without CF.

References

    1. Farrell PM, Rosenstein BJ, White TB, Accurso FJ, Castellani C, Cutting GR, et al. Guidelines for diagnosis of cystic fibrosis in newborns through older adults: Cystic Fibrosis Foundation consensus report. J Pediatr. 2008;153(2):S4–S14. - PMC - PubMed
    1. Foundation CF. Annual Data Report to the Center Directors. Bethesda, MD: Cystic Fibrosis Foundation, 2014.
    1. McIntosh JC, Schoumacher RA, Tiller RE. Pancreatic adenocarcinoma in a patient with cystic fibrosis. The American journal of medicine. 1988;85(4):592. - PubMed
    1. Tedesco FJ, Brown R, Schuman BM. Pancreatic carcinoma in a patient with cystic fibrosis. Gastrointestinal endoscopy. 1986;32(1):25–6. - PubMed
    1. Roberts JA, Tullett WM, Thomas JS, Galloway D, Stack BH. Bowel adenocarcinoma in a patient with cystic fibrosis. Scottish medical journal. 1986;31(2):109. - PubMed

Publication types